Skip to main content
Premium Trial:

Request an Annual Quote

RedShiftBio: Julien Bradley

RedShift BioAnalytics (RedShiftBio) , a provider of analytical solutions for protein characterization in biotherapeutic development, has appointed Julien Bradley as CEO. Bradley most recently served as vice president of marketing, corporate development and strategy at Quanterix, where he also previously served as VP of marketing and sales operations. He has also held senior roles at Phosphorus, OvaScience, and Thermo Fisher Scientific.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.